The type taxonomy for Highly Efficient Glucoamylase distinguishes four core categories: native enzyme preparations, recombinant expression systems, immobilized formats, and protein‑engineered variants. Native preparations, extracted from Aspergillus or Rhizopus species, dominate the commodity tier and contribute approximately 35 % of total volume, owing to their lower production cost despite broader activity spectra. Recombinant enzymes, produced in hosts such as Trichoderma reesei or Pichia pastoris, offer higher specific activity and tighter purity controls; they account for roughly 40 % of market value, particularly in high‑value food‑processing and pharmaceutical niches. Immobilized Glucoamylase, wherein the protein is covalently bound to silica, polymeric beads, or magnetic carriers, enables repeated‑batch operation and reduces downstream contamination; this segment captures about 15 % of revenue, reflecting its premium pricing and niche adoption in continuous‑flow reactors. Finally, protein‑engineered variants—generated through directed evolution or rational design—exhibit enhanced thermostability, altered pH optima, or reduced product inhibition, and represent the remaining 10 % of sales, driven by R&D‑intensive customers seeking performance gains. Collectively, this type‑based market taxonomy clarifies the value distribution across production technologies.